Associated Papers
Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: a systematic overview.
Liu M et al.
American Journal of Cancer Research, 2021
Genomics of lethal prostate cancer at diagnosis and castration resistance.
Mateo J et al.
The Journal of Clinical Investigation, 2020
31874108 (PubMed )
Supplement: jci-130-132031-s102.xlsx › shared_calls_primary-mCRPC
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.
Boysen G et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2018
Select a paper to view details